Portocanna specializes in the processing link of the value chain. By investing in complementary capabilities—namely, pharmaceutical operations, biotechnology capabilities, and supply chain management processes—we work with our partners to bring the highest quality pharma-grade products to patients across Europe.
The Medical Cannabis industry developed from local markets that faced heavy regulation. This reality created vertically integrated, centralized businesses that focus on a Seed-to Sale strategy. Today, as demand increases and this industry earns growing recognition, we believe that it is now critical to maximize efficiency gains in every link in the value chain.
By creating a large symbiotic network of specialized growers, distributors, and innovators in Europe, we will speed the evolution of the industry and bring patients improved access to the highest quality cannabis-derived products.